NASDAQ:CYTK

Cytokinetics Stock Predictions

NASDAQ Stock Exchange > Healthcare > Biotechnology

Open Broker Account

$65.27

+0.93 (+1.45%)

At Close: May 03, 2024

Currently predicting for Mon, 6 May 2024

Trading levels for CYTK

Fibonacci Support & Resistance Levels

		Level	Price
	Resistance	R3	67.23	3.00 %
		R2	66.62	2.06 %
		R1	66.24	1.48 %
Current price:			65.27
	Support	S1	65.01	-0.395 %
		S2	64.63	-0.98 %
		S3	64.02	-1.92 %

Accumulated Volume Support & Resistance Levels

		Level	Price
	Resistance	R3	73.09	11.98 %
		R2	71.15	9.01 %
		R1	67.68	3.69 %
Current price			65.27
	Support	S1	65.19	-0.123%
		S2	64.39	-1.35%
		S3	63.75	-2.33%

CYTK Predictions History

7 years ago
Blah predicted that CYTK for 2017-03-07 is going $12.00 (1.27%)

Rank:

About Cytokinetics

Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates include omecamtiv mecarbil, a novel cardiac myosin activator that is in Phase III clinical trial in pati... CYTK Profile

Golden Star

Ticker	Date	Change	Price
CVBF	May 01	2.75%	$16.75
FTSL	May 01	0.282%	$46.03
EQC	Apr 30	0.694%	$18.72
HRB	Apr 30	0.635%	$47.23
BSCQ	Apr 30	0.576%	$19.09
BSJP	Apr 29	0.306%	$22.91
LYG	Apr 29	1.56%	$2.56
ORA	Apr 29	4.68%	$64.48
DHT	Apr 24	3.10%	$11.28
LPLA	Apr 19	3.12%	$262.59

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by

Sign In